HSBC Downgrades Mindray Medical (MR) to Neutral
Tweet Send to a FriendGet Alerts MR Hot Sheet
Price: $41.36 -0.74%
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade MR Now!
HSBC downgraded Mindray Medical (NYSE: MR) from Overweight to Neutral with a price target of $43.20 (from $35.00).
For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.
Shares of Mindray Medical closed at $38.38 yesterday, with a 52 week range of $26.17-$38.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.
Shares of Mindray Medical closed at $38.38 yesterday, with a 52 week range of $26.17-$38.79.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Keefe, Bruyette & Woods Downgrades BlackRock (BLK) to Market Perform
- Jefferies Downgrades Bed Bath & Beyond (BBBY) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
HSBC
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
